134 related articles for article (PubMed ID: 3881948)
1. Aztreonam in the treatment of urinary tract infection.
Childs SJ
Am J Med; 1985 Feb; 78(2A):44-6. PubMed ID: 3881948
[TBL] [Abstract][Full Text] [Related]
2. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
Scully BE; Neu HC
Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
[TBL] [Abstract][Full Text] [Related]
3. Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections.
Swabb EA; Jenkins SA; Muir JG
Rev Infect Dis; 1985; 7 Suppl 4():S772-7. PubMed ID: 3909336
[TBL] [Abstract][Full Text] [Related]
4. Aztreonam versus cefamandole in the treatment of urinary tract infections.
Giamarellou H; Koratzanis G; Kanellakopoulou K; Galanakis N; Papoulias G; el Messidi M; Daikos G
Chemioterapia; 1984 Apr; 3(2):127-31. PubMed ID: 6543431
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of aztreonam and cefamandole in the treatment of serious urinary tract infections.
Tsouroutsoglou W; Sion ML; Stathopoulos GA; Kapoulas S; El-Messidi M; Paradelis AG
Methods Find Exp Clin Pharmacol; 1983; 5(6):385-90. PubMed ID: 6684719
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with aztreonam in urinary and respiratory tract infections.
Hollingsworth JA; Donohoe JF; Hone R; Keelan PJ
Curr Med Res Opin; 1984; 9(5):316-22. PubMed ID: 6397335
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with aztreonam in four Mediterranean countries.
Daikos GK
Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787
[TBL] [Abstract][Full Text] [Related]
8. Aztreonam therapy for complicated urinary tract infections caused by multidrug-resistant bacteria.
Cox CE
Rev Infect Dis; 1985; 7 Suppl 4():S767-71. PubMed ID: 3909335
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, in-vitro activity, therapeutic efficacy and clinical safety of aztreonam vs. cefotaxime in the treatment of complicated urinary tract infections.
Naber KG; Dette GA; Kees F; Knothe H; Grobecker H
J Antimicrob Chemother; 1986 Apr; 17(4):517-27. PubMed ID: 3710959
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of aztreonam in the treatment of serious gram-negative infections in a university hospital in Saudi Arabia.
Fayed DF; Dahmash NS; Saddique AA; Shibl AM
J Chemother; 1992 Jun; 4(3):167-70. PubMed ID: 1517810
[TBL] [Abstract][Full Text] [Related]
11. Clinical comparison of piperacillin and cefamandole in treatment of complicated urinary tract infections.
Resnick MI; Kursh ED
Urology; 1987 May; 29(5):570-4. PubMed ID: 3554702
[TBL] [Abstract][Full Text] [Related]
12. Role of aztreonam in urinary tract infections.
Roberts JA
Urology; 1988 Jun; 31(6 Suppl):39-44. PubMed ID: 3287749
[TBL] [Abstract][Full Text] [Related]
13. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
Henry SA; Bendush CB
Am J Med; 1985 Feb; 78(2A):57-64. PubMed ID: 3881950
[TBL] [Abstract][Full Text] [Related]
14. Use of aztreonam in patients suffering from urinary tract infections with contraindications for the use of aminoglycosides.
Fraschini F; Scaglione F; Alessandria M; Gattei G
Chemioterapia; 1986 Oct; 5(5):319-21. PubMed ID: 3791478
[TBL] [Abstract][Full Text] [Related]
15. Oral norfloxacin versus parenteral treatment of nosocomial urinary tract infection.
Cox CE; McCabe RE; Grad C
Am J Med; 1987 Jun; 82(6B):59-64. PubMed ID: 3300312
[TBL] [Abstract][Full Text] [Related]
16. A comparative study on aztreonam, ceftazidime and amikacin in the treatment of complicated urinary tract infections.
Melekos MD; Skoutelis A; Chryssanthopoulos C; Bassaris HP
J Chemother; 1991 Dec; 3(6):376-82. PubMed ID: 1819621
[TBL] [Abstract][Full Text] [Related]
17. Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia.
Schentag JJ; Vari AJ; Winslade NE; Swanson DJ; Smith IL; Simons GW; Vigano A
Am J Med; 1985 Feb; 78(2A):34-41. PubMed ID: 3881947
[TBL] [Abstract][Full Text] [Related]
18. Treatment of urinary tract infections in hospitalized patients: a double-blind comparison of cefonicid and cefamandole.
Cox CE; Jacob LS
Rev Infect Dis; 1984; 6 Suppl 4():S839-43. PubMed ID: 6395273
[TBL] [Abstract][Full Text] [Related]
19. Aztreonam compared with gentamicin for treatment of serious urinary tract infections.
Sattler FR; Moyer JE; Schramm M; Lombard JS; Appelbaum PC
Lancet; 1984 Jun; 1(8390):1315-8. PubMed ID: 6145024
[TBL] [Abstract][Full Text] [Related]
20. Aztreonam in the treatment of urinary tract infections: a multicenter trial.
Martelli A; Cortecchia V; Ventriglia L
Chemotherapy; 1989; 35 Suppl 1():8-14. PubMed ID: 2659294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
